Events2Join

How Penn Medicine Pioneered CAR T|Cell Therapy to Treat Cancer


CAR T Cell Therapy | Penn Medicine

These therapies use your body's own immune system to help fight cancer. Penn Medicine was a pioneer in the initial discovery of the first CAR T cell medications ...

How Penn Medicine Pioneered CAR T-Cell Therapy to Treat Cancer

Barshinger Cancer Institute—was developed by work led at Penn Medicine in Philadelphia. Penn Medicine has been a global leader in groundbreaking ...

Carl June on The Boundless Potential of CAR T Cell Therapy

Invented in the Perelman School of Medicine at University of Pennsylvania by Carl June, MD, the Richard W. Vague Professor in Immunotherapy, CAR ...

Dr. Carl June: Pioneer in CAR T Cell Immunotherapy - YouTube

This is the story of how Dr. Carl June paved the way for transformational breakthroughs in cancer treatment using CAR T cell therapy.

Carl June CAR T Cell Therapy Pioneer | By Penn Medicine - Facebook

CAR T cell therapy is a "living drug" that uses a patient's own immune system to fight cancer cells. Developed at Penn Medicine by Carl June ...

Carl June on the boundless potential of CAR T cell therapy

Six different CAR T cell therapies are now approved to treat various types of blood cancers. Carl June with a microphone in the Penn Medicine ...

Stream Award-Winning Documentary on Penn's CAR T Cancer Cure

In March 2024, Penn Medicine researchers reported some of the first meaningful results for using CAR T cell therapy to treat a solid tumor— ...

Study reveals inequities in access to CAR T cell therapy

CAR T cell therapy is a personalized form of cancer therapy that was pioneered at Penn Medicine and has brought hope to thousands of ...

CAR T Cell Therapy May Eliminate Tumor Cells Missed by Surgery

Preclinical study sets up clinical trials of CAR T cell · January 11, 2023. A digital illustration of CAR T cells · Contacts. Meagan Raeke C: 267-693-6224

FDA requires new warning for Penn-pioneered CAR-T therapy ...

Penn researcher Carl June led the Penn Medicine team that first used CAR-T cell therapy to treat adult leukemia patients in 2010, and later ...

Potential Strategy to Improve T Cell Therapy in Solid Tumors

CAR T cell therapy was pioneered at Penn Medicine by Carl H. June, MD, the Richard W. Vague Professor in Immunotherapy at Penn and director ...

FDA opens investigation into potential cancer risks of Penn ...

Penn researchers, including cancer scientist Carl June, first used CAR-T cell therapy to treat adult leukemia patients in 2010. A 2012 Penn ...

CHOP/Penn Study Shows CAR-T Cells Remain Active a Decade ...

Developed at CHOP and Penn, chimeric antigen receptor (CAR) T cell therapy is a type of immunotherapy that involves collecting a patient's T ...

Study reveals inequities in access to transformative CAR T cell therapy

CAR T cell therapy is a personalized form of cancer therapy that was pioneered at Penn Medicine and has brought hope to thousands of patients ...

Carl June CAR T Cell Therapy Pioneer - Penn Medicine - Facebook

CAR T cell therapy is a "living drug" that uses a patient's own immune system to fight cancer cells. Developed at Penn Medicine - Abramson ...

Combo immunotherapy makes waves of cancer-fighting T cells

August 29, 2024. A digital illustration of several T-cells attacking ... A digital illustration of several T-cells attacking a cancer cell in the human body.

What is CAR T Cell Therapy? Penn Medicine Explains - YouTube

CAR T cell therapy is unlocking the power of your immune system to fight all kinds of diseases, from cancer to autoimmune disease to heart ...

Penn Medicine developed CAR T cell therapy wins third FDA approval

“In just over a decade, we have moved from treating the very first patients with CAR T cell therapy and seeing them live healthy lives beyond ...

CAR T Cell Therapy Reaches Beyond Cancer - Penn Medicine

PHILADELPHIA— Engineered immune cells, known as CAR T cells, have shown the world what personalized immunotherapies can do to fight blood ...

FDA says CAR-T therapy pioneered at UPenn may be causing cancer

Chimeric antigen receptor T cell, CAR-T, therapy has been hailed as a breakthrough treatment, and possibly a cure, for some types of blood ...